Partner Courtenay Brinckerhoff, Vice Chair of the Intellectual Property Owners Association’s Patent Office Practice Committee, was quoted in the IP Watchdog article, “Users Lament PAIR Changes During USPTO Forum.” Brinckerhoff said that Private PAIR is also problematic. “To the extent the separation [between Public and Private PAIR] was supposed to help Private PAIR, it’s broken,” she said. “I’m having better luck getting into Public PAIR to check a case, but I can’t get everything [I need].”
Brinckerhoff added that such hindrances are particularly problematic in the case of portfolio transfers, for instance. “The first thing our transfer team does is go on to PAIR to verify the status and get an update; that’s significantly handicapped by this change. It’s time sensitive.”
People
Related News
May 1, 2026
In the News
David Rosen Weighs in on SCOTUS Review of Skinny Label Patent Dispute
Foley & Lardner LLP partner David Rosen is featured across the media for his perspective on the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.
April 27, 2026
In the News
Jesse Neil Featured as a Distinguished Leader in Law.com's Southeastern Legal Awards
Foley & Lardner LLP partner Jesse Neil is recognized in Law.com as one of the Distinguished Leader honorees for the 2026 Southeastern Legal Awards.
April 27, 2026
In the News
David Rosen and William Holtz Analyze FDA Approval Speed, Biotech Pressures
Foley & Lardner LLP attorneys David Rosen and William Holtz are quoted in the PharmaVoice article, “FDA’s need for speed could strain small biotechs. Here’s how they can keep up,” examining the FDA’s accelerated drug approval initiatives and its impact on smaller pharmaceutical companies.